Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma

The establishment of more effective treatments that can circumvent chemoresistance in Multiple Myeloma (MM) is a priority. Although bortezomib (BTZ) is one of the most potent proteasome inhibitors available, still possesses limitations related to dose limiting side effects. Several strategies have b...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Control Release
Main Authors: de la Puente, Pilar, Luderer, Micah J., Federico, Cinzia, Jin, Abbey, Gilson, Rebecca C., Egbulefu, Christopher, Alhallak, Kinan, Shah, Shruti, Muz, Barbara, Sun, Jennifer, King, Justin, Kohnen, Daniel, Salama, Noha Nabil, Achilefu, Samuel, Vij, Ravi, Azab, Abdel Kareem
Format: Artigo
Sprog:Inglês
Udgivet: 2017
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6056271/
https://ncbi.nlm.nih.gov/pubmed/29196043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2017.11.045
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker